Code of ethics and Best Practices Charters
We have adopted a Group Code of ethics. It lists the commitments, practices and modes of conduct that our company has chosen and instituted for both its internal and external relations. The Code of ethics is a reference document that formalizes the ethical framework all employees must adhere to on a daily basis when performing their duties and making responsible decisions. Informational meetings are held to ensure that every employee in France and around the world is given a chance to learn and understand what the Group Code of ethics contains and the terms of enforcing it. E-learning training programs will also be deployed starting in mid-2015.
In addition to the Code of ethics, we have also introduced specific charters like the Purchasing Charter and the Good Promotional Practices Charter in order to provide details on the proper conduct to use in certain of our business activities and professions.
We ensure that our brands respect the principles of responsible communication. Press releases about environmental allegations, in particular, are validated by our competent regulatory departments and the Sustainable Development Division.
We have a detailing structure that is suited to changes in the pharmaceutical market and its products, as well as the quality requirements of national regulatory authorities.
In line with its ethical values, our company complies with the Information Charter through direct contact and canvassing to promote drugs. It has implemented a comprehensive quality system covering this activity, as part of a continuous improvement initiative, through a Quality Policy, the success of which is based on the commitment of the Management team and employees.
Since 2007, our French detailing networks* have thus been certified by an organization duly accredited by COFRAC (French accreditation body), in accordance with the standards implemented by the French Health Authority. They comply with the ethical rules that apply to promotional information on drugs.
Our international subsidiaries enforce the national regulations that apply to them, as well as our charter of best practices for promotion.
* network promoting at least one reimbursed drug.